Benzinga · Aug 24, 2026
Ashland Launches permexa Sodium Caprate To Advance Oral Delivery Of Peptides, Biologics, And GLP‑1 Therapies
Ashland Inc. (NYSE:ASH), is announcing the launch of permexa™ sodium caprate, a high-performance intestinal permeation enhancer designed to support the scalable development and commercialization of oral peptide,

